期刊文献+

原发性甲状旁腺功能亢进合并甲状腺病变的临床病因分析 被引量:3

暂未订购
导出
摘要 目的通过临床资料的分析,探讨原发性甲状旁腺功能亢进(PHPT)与甲状腺病变的关系及发病情况。方法对我院1991~2009年收治的105例PHPT病例资料进行回顾性分析,统计合并甲状腺病变的详细发病情况及相关的内分泌指标,使用SPSS统计软件分析两病并发的相关因素。结果本组病例合并甲状腺病变的并发率为39.0%,≥40岁女性并发率为60.5%。甲状腺病变主要为结节性甲状腺肿(37/41)。两病并发的主要相关因素为年龄与性别,而与甲状旁腺激素、促甲状腺激素、降钙素等因素无明显相关。结论 PHPT患者中甲状腺病变高发的原因可能是两病均高发于中老年女性。在PHPT的诊治中不能忽视甲状腺疾病的并存问题。
机构地区 北京积水潭医院
出处 《山东医药》 CAS 北大核心 2011年第40期91-93,共3页 Shandong Medical Journal
  • 相关文献

参考文献8

  • 1Kosem M,Algün E,Kotan C,et al.Coexistent thyroid pathologies and high rate of papillary cancer in patients with primary hyperparathyroidism:controversies about minimal invasive parathyroid surgery[J].Acta Chir Belg,2004,104(5):568-571.
  • 2Milas M,Mensah A,Alghotl M,et al.The impact of office neck ul trasonography on reducing unnecessary thyroid surgery in patients undergoing parathyroidectomy[J].Thyroid,2005,15(9):1055-1059.
  • 3徐少明,郑毅雄,王平,刘颖斌,李志宇,田华.原发性甲状旁腺功能亢进症并发甲状腺疾病21例临床分析[J].中华普通外科杂志,2007,22(2):81-84. 被引量:8
  • 4Denizot A,Dadoun F,Meyer-Dutour A,et al.Screening for primry hyperparathyroidism before thyroid surgery:a prospective study[J].Surgery,2002,131 (3):264-269.
  • 5Abboud B,Sleilaty G,Mansour E,et al.Prevalence and risk factors for primary hyperparathyroidism in hyperthyroid patients[J].Head Neck,2006,28(5):420-426.
  • 6Stephen AE,Chen KT,Milas M,et al.The coming of age of radiation-induced hyperparathyroidism:evolving patterns of thyroid and parathyroid disease after head and neck irradiation[J].Surgery,2004,136(6):1143-1153.
  • 7Bentrem DJ,Angelos P,Talamonti MS,et al.Is preoperative investigation of the thyroid justified in patients undergoing parathyroidectomy for hyperparathyroidism[J].Thyroid,2002,12(12):1109-1112.
  • 8邢小平,王鸥,孟迅吾,夏维波,李梅,姜艳,韩桂艳,胡莹莹,刘怀成.北京与纽约原发性甲状旁腺功能亢进症临床表现的比较[J].诊断学理论与实践,2006,5(6):483-486. 被引量:24

二级参考文献25

  • 1王鸥,邢小平,孟迅吾,夏维波,李梅,胡莹莹,刘怀成,余卫,管珩,朱预,刘彤华.MEN患者甲状旁腺功能亢进症的临床表现[J].中华内分泌代谢杂志,2004,20(4):296-299. 被引量:13
  • 2孟迅吾,邢小平,刘书勤,詹志伟,周学瀛,刘怀成,史轶蘩,沙利进,余卫,解毓章.原发性甲状旁腺功能亢进症的诊断(附134例分析)[J].中国医学科学院学报,1994,16(1):13-19. 被引量:43
  • 3徐少明,吴育连.Ⅲ型多发性内分泌瘤病[J].中华外科杂志,1995,33(6):348-350. 被引量:6
  • 4徐少明,吴峥嵘,王平,陈健,刘颖斌.微创直接甲状旁腺肿瘤切除术34例临床分析[J].中华外科杂志,2006,44(5):337-338. 被引量:9
  • 5[2]Melton LJ 3rd.The epidemiology of primary hyperparathyroidism in North America[J].J Bone Miner Res,2002,17(Suppl 2):N12-17.
  • 6[7]Bilezikian JP,Meng X,Shi Y,et al.Primary hyperparathyroidism in women:a tale of two cities--New York and Beijing[J].Int J Fertil Womens Med,2000,45(2):158-165.
  • 7[8]Bilezikian JP,Potts JT Jr.Asymptomatic primary hyperparathyroidism:new issues and new questions--bridging the past with the future[J].J Bone Miner Res,2002,17(Suppl 2):N57-67.
  • 8[9]Rao DS,Agarwal G,Talpos GB,et al.Role of vitamin D and calcium nutrition in disease expression and parathyroid tumor growth in primary hyperparathyroidism:a global perspective[J].J Bone Miner Res,2002,17(Suppl 2):N75-80.
  • 9[12]Kaplan FS,Soffer SR,Fallon MD,et al.Osteomalacia as a very late manifestation of primary hyperparathyroidism[J].Clin Orthop Relat Res,1988,26(228):26-32.
  • 10史轶蘩 于国宁 张重哲.原发性甲状旁腺机能亢进症23例临床分析[J].中华内科杂志,1980,19(3):196-196.

共引文献30

同被引文献34

  • 1徐少明,郑毅雄,王平,刘颖斌,李志宇,田华.原发性甲状旁腺功能亢进症并发甲状腺疾病21例临床分析[J].中华普通外科杂志,2007,22(2):81-84. 被引量:8
  • 2Lee PK, Jarosek SL, Vifnig BA, et al. Trends in the incidence and treatment of parathyroid cancer in the United States. Cancer, 2007, 109(9): 1736-1741.
  • 3Basceken S1, Genc V, Ersoz S, et al. Is local resection sufficient for parathyroid carcinoma?. Clinics (Sao Paulo), 2015, 70(4): 247-249.
  • 4Schaapveld M, Iorna FH, Aben KK, et al. Incidence and prognosis of parathyroid gland carcinoma: a population-based study in The Netherlands estimating the preoperative diagnosis. Am J Surg, 2011, 202(5): 590-597.
  • 5Sharretts JM, Kebebew E, Simonds WF. Parathyroid cancer. Semin Oncol, 2010, 37(6): 580-590.
  • 6Witteveen JE, Haak HR, Kievit J, et al. Challenges and pitfalls in the management of parathyroid carcinoma: 17-year follow-up of a case and review of the literature. Horm Cancer, 2010, 1(4): 205-214.
  • 7Korpi-Hy6v:ilti E, Cranston T, Ryh:nen E, et al. CDC73 intragenic deletion in familial primary hyperparathyroidism associated with parathyroid carcinoma, l Clin Endocrinol Metab, 2014, 99(9): 3044- 3048.
  • 8Sulaiman L, Haglund F, Hashemi J, et al. Genome-wide and locus specific alterations in CDC73/HRPT2-mutated parathyroid tumors. PLoS One, 2012, 7(9): e46325.
  • 9Wang O, Wang C, Nie M, et al. Novel HRPT2/CDC73 gene muta- tions and loss of expression of parafibromin in Chinese patients with clinically sporadic parathyroid carcinomas. PLoS One, 2012, 7(9): e45567.
  • 10Milas M, Mensah A, Alghoul M, et al. The impact of office neck ultrasonography on reducing unnecessary thyroid surgery in patients undergoing parathyroidectomy. Thyroid, 2005, 15(9): 1055-1059.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部